Recognition in ANDA Litigation Intelligence Report
The firm ranked among the most impactful firms in pharmaceutical IP litigation
The intellectual property law firm of Panitch Schwarze Belisario & Nadel LLP has been recognized for its outstanding contributions to the field, being highlighted in the prestigious 2025 ANDA Litigation Intelligence Report. This report spotlights law firms that play a significant role in litigation connected to Abbreviated New Drug Applications (ANDA), a critical process for securing approval for generic drugs in the U.S. under the Hatch-Waxman Act. The firms listed are evaluated based on their engagement in cases, success rates, and impactful strategies during the litigation.
Insights from the Legal Team
Partner Travis W. Bliss, Ph.D., expressed pride in the firm's inclusion among elite law firms in the pharmaceutical IP sector. "We are honored to be included among such high-performing law firms and attorneys in the pharmaceutical IP space," Bliss stated. He emphasized the firm's commitment to protecting intellectual property rights within the life sciences, noting the team's dedication to staying informed about the latest industry developments and strategizing to achieve optimal results for their clients.
Areas of Expertise and Litigation Practices
Panitch Schwarze's attorneys are well-versed in litigating cases across various legal platforms, including federal and state courts, as well as specialized forums such as the International Trade Commission, the Patent and Trademark Office's Patent Trial and Appeal Board (PTAB), and Trademark Trial and Appeal Board (TTAB). They handle a broad spectrum of intellectual property disputes encompassing patents, trademarks, copyrights, trade secrets, and IP licensing. The firm's proficient handling of Post Grant Reviews and Inter Partes Reviews at the PTAB, along with trademark opposition and cancellation proceedings at the TTAB, exemplifies their extensive capabilities.
Strategic Protection for Clients
Moreover, the firm dedicates efforts to developing online enforcement protocols aimed at safeguarding clients' products from counterfeiters and imitators. This comprehensive approach ensures that clients not only defend their intellectual rights but also enhance their market presence against infringement risks.
About the Firm
Panitch Schwarze Belisario & Nadel LLP stands as a distinguished boutique intellectual property law firm with multiple offices located strategically across the eastern United States. The firm specializes in providing innovative litigation, licensing, and advisory services concerning a diverse range of intellectual property including patents, trademarks, copyrights, and trade secrets. With robust connections to a network of associates globally, Panitch Schwarze's legal professionals are adept at offering well-rounded intellectual property guidance that spans across international borders.
Contact Information
For inquiries, please reach out to Sarah Larson at the firm. Their commitment to client success is paramount, and they are available to assist with any questions or legal concerns related to intellectual property law.
Frequently Asked Questions
What is the ANDA Litigation Intelligence Report?
The ANDA Litigation Intelligence Report is a prestigious guide that highlights law firms involved in Abbreviated New Drug Application litigation, reflecting their performance and strategies.
Why is Panitch Schwarze Belisario & Nadel LLP recognized?
The firm is recognized for its impactful role in pharmaceutical IP litigation and its strategic successes in various intellectual property disputes.
What types of litigation does Panitch Schwarze handle?
They handle various adversarial IP disputes, including patent, trademark, copyright, trade secret violations, and licensing litigations.
Who can I contact for legal inquiries at the firm?
You can reach out to Sarah Larson for any legal inquiries or assistance regarding intellectual property law.
How does the firm protect clients' products?
The firm develops online enforcement protocols to safeguard their clients' products from imitation and infringement.
